secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aspira Women's Health Inc. (AWHL)
CIK:        0000926617
Form:       8-K
Filed at:   2026-06-22T13:13:14+00:00
Accession:  0000926617-26-000047
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Aspira Women's Health CEO Michael Buhle departs; Chairman John Fraser named interim CEO
--------------------------------------------------------------------------------

- Michael Buhle ceased as CEO effective June 17, 2026; no disagreement with company operations.
- Board appointed Chairman John Fraser as Interim CEO and Principal Executive Officer.
- Separation agreement with Buhle not yet finalized; Company will file amendment within 4 business days.
- John Fraser, age 66, is co-founder and co-portfolio manager of Seamark Capital.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/926617/000092661726000047/0000926617-26-000047-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/926617/000092661726000047/awhl-20260617x8k.htm
  HTML page:      https://secwatch.observer/filing/0000926617-26-000047

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer